H. Karam et al., ROLE OF ENDOTHELIN IN ACUTE-RENAL-FAILURE DUE TO RHABDOMYOLYSIS IN RATS, The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 481-486
Rhabdomyolysis and other causes of massive myoglobin release are often
complicated by an acute ischemic renal failure. We tested the hypothe
sis that endothelin-1, the most potent renal vasoconstrictor known, pl
ays a role in the renal toxicity of myoglobin. For this purpose, we in
duced rhabdomyolysis (8 ml/kg i.m. of a 50% glycerol solution) in rats
pretreated or not pretreated with bosentan, a novel potent nonpeptide
endothelin receptor antagonist. Glycerol decreased renal function dra
matically, increased proteinuria and induced a massive tubular necrosi
s. This effect was associated with a 22% increase in plasma endothelin
concentration. Bosentan prevented the decrease in creatinine clearanc
e (1.12 +/- 0.07 ml/min vs. 0.83 +/- 0.05 ml/min, P < .01), the increa
se in proteinuria (19.9 mg/24 hr vs. 31.8 mg/24 hr, P < .001) and the
tubular necrosis induced by glycerol (as assessed by histopathological
evaluation), without affecting myoglobinuria. Involvement of endothel
in was further suggested by the observation that myoglobin could marke
dly increase endothelin-1 release by rat mesangial cells in culture. W
e conclude that endothelin is, at least in part, responsible for the m
assive tubular necrosis observed in myoglobinuric nephropathy.